Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1.55	1.55	-	1	5	15
Revenue Growth (YoY)	-	-	-	-80.00%	-66.67%	-
Cost of Revenue	0.01	-	-	-	-	-
Gross Profit	1.53	1.55	-	1	5	15
Selling, General & Admin	50.67	45.58	27.75	31.05	24.81	19.4
Research & Development	16.38	18.11	14.36	31.05	39.83	38.67
Total Operating Expenses	67.05	63.69	42.1	62.1	64.64	58.07
Operating Income	-65.28	-62.14	-42.1	-61.1	-59.64	-43.07
Interest Income	3.96	2.92	4.16	3.97	1.25	0.22
Interest Expense	-7.04	-3.84	-3.58	-2.55	-	-
Total Non-Operating Income (Expense)	-3.08	-0.92	0.58	1.41	1.25	0.22
Pretax Income	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Net Income	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Net Income to Common	-68.36	-63.06	-41.52	-59.69	-58.39	-42.85
Shares Outstanding (Basic)	100	84	62	43	42	42
Shares Outstanding (Diluted)	100	84	62	43	42	42
Shares Change (YoY)	50.69%	34.84%	44.82%	1.19%	1.47%	42.56%
EPS (Basic)	-0.67	-0.75	-0.67	-1.39	-1.38	-1.02
EPS (Diluted)	-0.67	-0.75	-0.67	-1.39	-1.38	-1.02
Shares Outstanding	117.79	106.24	53.35	33.48	42.8	29.9
Free Cash Flow	-51.48	-49.34	-28.88	-46.54	-52.74	-33.22
Free Cash Flow Per Share	-0.52	-0.59	-0.46	-1.08	-1.24	-0.79
Gross Margin	99.09%	100.00%	-	100.00%	100.00%	100.00%
Operating Margin	-4222.51%	-4019.40%	-	-6109.80%	-1192.84%	-287.15%
Profit Margin	-4421.93%	-4078.78%	-	-5968.50%	-1167.76%	-285.69%
FCF Margin	-3330.08%	-3191.66%	-	-4653.60%	-1054.82%	-221.49%
EBITDA	-65.14	-62.03	-42	-61.01	-59.55	-42.98
EBITDA Margin	-4213.26%	-4012.03%	-	-6100.60%	-1191.06%	-286.53%
EBIT	-65.28	-62.14	-42.1	-61.1	-59.64	-43.07
EBIT Margin	-4222.51%	-4019.40%	-	-6109.80%	-1192.84%	-287.15%

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q